Table 1

Formulations of polypill available for prescription, and recommended indications

Clinical history

Intervention group


Coronary heart disease

Formulation 1*


Cerebrovascular disease

Formulation 2**


Both or other athero-thrombotic vascular disease

Either Formulation 1* or 2**


>15% 5-year CVD risk, but without established CVD

Formulation 2**


*Polypill with aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, atenolol 50 mg

**Polypill with aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg

Liu et al. BMC Public Health 2010 10:458   doi:10.1186/1471-2458-10-458

Open Data